Tag: #Global Trends

Corporate Update At the 2026 J.P. Morgan Healthcare Conference, Ionis Pharmaceuticals announced significant adjustments to its commercial expectations for its... Read more

Market Summary The second day of the annual healthcare event in San Francisco witnessed a significant shift in how major... Read more

The French government has officially unveiled a strategic roadmap to combat the rising tide of health-related misinformation. This initiative is... Read more

On January 8, 2026, the multinational biopharmaceutical giant AstraZeneca officially announced the appointment of a new Head of Investor Relations.... Read more

On January 12, 2026, the European Commission officially approved Sanofi’s Teizeild (teplizumab). This marks the first disease-modifying therapy authorized in... Read more

January 2026 has marked a vibrant start for the biomedical venture capital market with the launch of three new funds,... Read more

Alveus Therapeutics has made its debut following a successful $160 million Series A financing round. Led by prominent healthcare investors... Read more

Swiss drugmaker Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing plant in Winter Park, Florida. This... Read more

Johnson & Johnson (J&J) has officially joined the ranks of biopharma giants striking "Most-Favored-Nation" (MFN) drug pricing agreements with the... Read more